nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—Methotrexate—psoriatic arthritis	0.442	1	CbGbCtD
Brimonidine—Influenza—Triamcinolone—psoriatic arthritis	0.00107	0.00192	CcSEcCtD
Brimonidine—Dry skin—Dexamethasone—psoriatic arthritis	0.00103	0.00185	CcSEcCtD
Brimonidine—Dry skin—Betamethasone—psoriatic arthritis	0.00103	0.00185	CcSEcCtD
Brimonidine—Coma—Methotrexate—psoriatic arthritis	0.00103	0.00185	CcSEcCtD
Brimonidine—Bronchitis—Triamcinolone—psoriatic arthritis	0.00103	0.00185	CcSEcCtD
Brimonidine—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00101	0.00181	CcSEcCtD
Brimonidine—Lethargy—Prednisone—psoriatic arthritis	0.001	0.00179	CcSEcCtD
Brimonidine—Osteoarthritis—Prednisone—psoriatic arthritis	0.000981	0.00176	CcSEcCtD
Brimonidine—Bradycardia—Prednisolone—psoriatic arthritis	0.000951	0.0017	CcSEcCtD
Brimonidine—Face oedema—Prednisone—psoriatic arthritis	0.000947	0.0017	CcSEcCtD
Brimonidine—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.000942	0.00169	CcSEcCtD
Brimonidine—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00093	0.00167	CcSEcCtD
Brimonidine—Visual impairment—Prednisolone—psoriatic arthritis	0.0009	0.00161	CcSEcCtD
Brimonidine—Dry skin—Prednisone—psoriatic arthritis	0.000899	0.00161	CcSEcCtD
Brimonidine—Bradycardia—Triamcinolone—psoriatic arthritis	0.000874	0.00157	CcSEcCtD
Brimonidine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000872	0.00156	CcSEcCtD
Brimonidine—Visual disturbance—Methotrexate—psoriatic arthritis	0.000865	0.00155	CcSEcCtD
Brimonidine—Rhinitis—Triamcinolone—psoriatic arthritis	0.000861	0.00154	CcSEcCtD
Brimonidine—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000859	0.00154	CcSEcCtD
Brimonidine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000852	0.00153	CcSEcCtD
Brimonidine—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.000844	0.00151	CcSEcCtD
Brimonidine—Conjunctivitis—Betamethasone—psoriatic arthritis	0.000844	0.00151	CcSEcCtD
Brimonidine—Lethargy—Methotrexate—psoriatic arthritis	0.000837	0.0015	CcSEcCtD
Brimonidine—Arrhythmia—Prednisolone—psoriatic arthritis	0.000834	0.0015	CcSEcCtD
Brimonidine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000826	0.00148	CcSEcCtD
Brimonidine—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00082	0.00147	CcSEcCtD
Brimonidine—Erythema—Prednisolone—psoriatic arthritis	0.000813	0.00146	CcSEcCtD
Brimonidine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000801	0.00144	CcSEcCtD
Brimonidine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000795	0.00143	CcSEcCtD
Brimonidine—Bradycardia—Betamethasone—psoriatic arthritis	0.000793	0.00142	CcSEcCtD
Brimonidine—Bradycardia—Dexamethasone—psoriatic arthritis	0.000793	0.00142	CcSEcCtD
Brimonidine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000777	0.00139	CcSEcCtD
Brimonidine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000774	0.00139	CcSEcCtD
Brimonidine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000772	0.00138	CcSEcCtD
Brimonidine—Arrhythmia—Triamcinolone—psoriatic arthritis	0.000767	0.00138	CcSEcCtD
Brimonidine—Vision blurred—Prednisolone—psoriatic arthritis	0.000766	0.00137	CcSEcCtD
Brimonidine—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.000765	0.00137	CcSEcCtD
Brimonidine—Depression—Prednisone—psoriatic arthritis	0.000754	0.00135	CcSEcCtD
Brimonidine—Visual impairment—Betamethasone—psoriatic arthritis	0.000751	0.00135	CcSEcCtD
Brimonidine—Visual impairment—Dexamethasone—psoriatic arthritis	0.000751	0.00135	CcSEcCtD
Brimonidine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000751	0.00135	CcSEcCtD
Brimonidine—Erythema—Triamcinolone—psoriatic arthritis	0.000748	0.00134	CcSEcCtD
Brimonidine—Erythema—Methylprednisolone—psoriatic arthritis	0.000746	0.00134	CcSEcCtD
Brimonidine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000732	0.00131	CcSEcCtD
Brimonidine—Syncope—Prednisolone—psoriatic arthritis	0.000729	0.00131	CcSEcCtD
Brimonidine—Eye disorder—Dexamethasone—psoriatic arthritis	0.000728	0.00131	CcSEcCtD
Brimonidine—Eye disorder—Betamethasone—psoriatic arthritis	0.000728	0.00131	CcSEcCtD
Brimonidine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000714	0.00128	CcSEcCtD
Brimonidine—Angiopathy—Dexamethasone—psoriatic arthritis	0.000707	0.00127	CcSEcCtD
Brimonidine—Angiopathy—Betamethasone—psoriatic arthritis	0.000707	0.00127	CcSEcCtD
Brimonidine—Hypertension—Prednisolone—psoriatic arthritis	0.000702	0.00126	CcSEcCtD
Brimonidine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000696	0.00125	CcSEcCtD
Brimonidine—Arrhythmia—Betamethasone—psoriatic arthritis	0.000696	0.00125	CcSEcCtD
Brimonidine—Bradycardia—Prednisone—psoriatic arthritis	0.000691	0.00124	CcSEcCtD
Brimonidine—Discomfort—Prednisolone—psoriatic arthritis	0.000684	0.00123	CcSEcCtD
Brimonidine—Erythema—Dexamethasone—psoriatic arthritis	0.000678	0.00122	CcSEcCtD
Brimonidine—Erythema—Betamethasone—psoriatic arthritis	0.000678	0.00122	CcSEcCtD
Brimonidine—Syncope—Triamcinolone—psoriatic arthritis	0.00067	0.0012	CcSEcCtD
Brimonidine—Syncope—Methylprednisolone—psoriatic arthritis	0.000669	0.0012	CcSEcCtD
Brimonidine—Oedema—Prednisolone—psoriatic arthritis	0.000663	0.00119	CcSEcCtD
Brimonidine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000657	0.00118	CcSEcCtD
Brimonidine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000656	0.00118	CcSEcCtD
Brimonidine—Shock—Prednisolone—psoriatic arthritis	0.000653	0.00117	CcSEcCtD
Brimonidine—Cough—Triamcinolone—psoriatic arthritis	0.000652	0.00117	CcSEcCtD
Brimonidine—Tachycardia—Prednisolone—psoriatic arthritis	0.000647	0.00116	CcSEcCtD
Brimonidine—Hypertension—Triamcinolone—psoriatic arthritis	0.000645	0.00116	CcSEcCtD
Brimonidine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000644	0.00115	CcSEcCtD
Brimonidine—Myalgia—Triamcinolone—psoriatic arthritis	0.000636	0.00114	CcSEcCtD
Brimonidine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000635	0.00114	CcSEcCtD
Brimonidine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000635	0.00114	CcSEcCtD
Brimonidine—Eye disorder—Prednisone—psoriatic arthritis	0.000634	0.00114	CcSEcCtD
Brimonidine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000633	0.00113	CcSEcCtD
Brimonidine—Drowsiness—Methotrexate—psoriatic arthritis	0.000632	0.00113	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000631	0.00113	CcSEcCtD
Brimonidine—Depression—Methotrexate—psoriatic arthritis	0.00063	0.00113	CcSEcCtD
Brimonidine—Flushing—Prednisone—psoriatic arthritis	0.00063	0.00113	CcSEcCtD
Brimonidine—Discomfort—Triamcinolone—psoriatic arthritis	0.000629	0.00113	CcSEcCtD
Brimonidine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000627	0.00112	CcSEcCtD
Brimonidine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000622	0.00112	CcSEcCtD
Brimonidine—Angiopathy—Prednisone—psoriatic arthritis	0.000616	0.0011	CcSEcCtD
Brimonidine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000614	0.0011	CcSEcCtD
Brimonidine—Immune system disorder—Prednisone—psoriatic arthritis	0.000613	0.0011	CcSEcCtD
Brimonidine—Oedema—Triamcinolone—psoriatic arthritis	0.00061	0.00109	CcSEcCtD
Brimonidine—Syncope—Dexamethasone—psoriatic arthritis	0.000608	0.00109	CcSEcCtD
Brimonidine—Syncope—Betamethasone—psoriatic arthritis	0.000608	0.00109	CcSEcCtD
Brimonidine—Arrhythmia—Prednisone—psoriatic arthritis	0.000606	0.00109	CcSEcCtD
Brimonidine—Infection—Triamcinolone—psoriatic arthritis	0.000606	0.00109	CcSEcCtD
Brimonidine—Infection—Methylprednisolone—psoriatic arthritis	0.000605	0.00108	CcSEcCtD
Brimonidine—Shock—Triamcinolone—psoriatic arthritis	0.0006	0.00108	CcSEcCtD
Brimonidine—Insomnia—Prednisolone—psoriatic arthritis	0.0006	0.00108	CcSEcCtD
Brimonidine—Shock—Methylprednisolone—psoriatic arthritis	0.000599	0.00107	CcSEcCtD
Brimonidine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000597	0.00107	CcSEcCtD
Brimonidine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000596	0.00107	CcSEcCtD
Brimonidine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000596	0.00107	CcSEcCtD
Brimonidine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000596	0.00107	CcSEcCtD
Brimonidine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000595	0.00107	CcSEcCtD
Brimonidine—Mental disorder—Prednisone—psoriatic arthritis	0.000594	0.00107	CcSEcCtD
Brimonidine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000594	0.00107	CcSEcCtD
Brimonidine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000591	0.00106	CcSEcCtD
Brimonidine—Erythema—Prednisone—psoriatic arthritis	0.000591	0.00106	CcSEcCtD
Brimonidine—Hypertension—Dexamethasone—psoriatic arthritis	0.000586	0.00105	CcSEcCtD
Brimonidine—Hypertension—Betamethasone—psoriatic arthritis	0.000586	0.00105	CcSEcCtD
Brimonidine—Myalgia—Dexamethasone—psoriatic arthritis	0.000577	0.00104	CcSEcCtD
Brimonidine—Myalgia—Betamethasone—psoriatic arthritis	0.000577	0.00104	CcSEcCtD
Brimonidine—Anxiety—Betamethasone—psoriatic arthritis	0.000575	0.00103	CcSEcCtD
Brimonidine—Anxiety—Dexamethasone—psoriatic arthritis	0.000575	0.00103	CcSEcCtD
Brimonidine—Discomfort—Betamethasone—psoriatic arthritis	0.000571	0.00102	CcSEcCtD
Brimonidine—Discomfort—Dexamethasone—psoriatic arthritis	0.000571	0.00102	CcSEcCtD
Brimonidine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000569	0.00102	CcSEcCtD
Brimonidine—Pain—Prednisolone—psoriatic arthritis	0.000567	0.00102	CcSEcCtD
Brimonidine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000563	0.00101	CcSEcCtD
Brimonidine—Vision blurred—Prednisone—psoriatic arthritis	0.000557	0.000998	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000556	0.000997	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000555	0.000994	CcSEcCtD
Brimonidine—Oedema—Dexamethasone—psoriatic arthritis	0.000554	0.000993	CcSEcCtD
Brimonidine—Oedema—Betamethasone—psoriatic arthritis	0.000554	0.000993	CcSEcCtD
Brimonidine—Insomnia—Triamcinolone—psoriatic arthritis	0.000552	0.000989	CcSEcCtD
Brimonidine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000551	0.000987	CcSEcCtD
Brimonidine—Infection—Betamethasone—psoriatic arthritis	0.00055	0.000986	CcSEcCtD
Brimonidine—Infection—Dexamethasone—psoriatic arthritis	0.00055	0.000986	CcSEcCtD
Brimonidine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000548	0.000982	CcSEcCtD
Brimonidine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000547	0.00098	CcSEcCtD
Brimonidine—Visual impairment—Methotrexate—psoriatic arthritis	0.000547	0.00098	CcSEcCtD
Brimonidine—Shock—Dexamethasone—psoriatic arthritis	0.000545	0.000977	CcSEcCtD
Brimonidine—Shock—Betamethasone—psoriatic arthritis	0.000545	0.000977	CcSEcCtD
Brimonidine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000544	0.000975	CcSEcCtD
Brimonidine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000543	0.000973	CcSEcCtD
Brimonidine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000543	0.000973	CcSEcCtD
Brimonidine—Tachycardia—Betamethasone—psoriatic arthritis	0.00054	0.000969	CcSEcCtD
Brimonidine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00054	0.000969	CcSEcCtD
Brimonidine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000537	0.000963	CcSEcCtD
Brimonidine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000536	0.000961	CcSEcCtD
Brimonidine—Eye disorder—Methotrexate—psoriatic arthritis	0.00053	0.00095	CcSEcCtD
Brimonidine—Syncope—Prednisone—psoriatic arthritis	0.00053	0.00095	CcSEcCtD
Brimonidine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000526	0.000944	CcSEcCtD
Brimonidine—Fatigue—Triamcinolone—psoriatic arthritis	0.000526	0.000943	CcSEcCtD
Brimonidine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000525	0.000941	CcSEcCtD
Brimonidine—Pain—Triamcinolone—psoriatic arthritis	0.000522	0.000935	CcSEcCtD
Brimonidine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000519	0.000931	CcSEcCtD
Brimonidine—Hypotension—Dexamethasone—psoriatic arthritis	0.000517	0.000927	CcSEcCtD
Brimonidine—Hypotension—Betamethasone—psoriatic arthritis	0.000517	0.000927	CcSEcCtD
Brimonidine—Angiopathy—Methotrexate—psoriatic arthritis	0.000515	0.000923	CcSEcCtD
Brimonidine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000512	0.000918	CcSEcCtD
Brimonidine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000511	0.000916	CcSEcCtD
Brimonidine—Hypertension—Prednisone—psoriatic arthritis	0.00051	0.000914	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000504	0.000904	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000504	0.000904	CcSEcCtD
Brimonidine—Myalgia—Prednisone—psoriatic arthritis	0.000503	0.000902	CcSEcCtD
Brimonidine—Arthralgia—Prednisone—psoriatic arthritis	0.000503	0.000902	CcSEcCtD
Brimonidine—Anxiety—Prednisone—psoriatic arthritis	0.000501	0.000899	CcSEcCtD
Brimonidine—Insomnia—Betamethasone—psoriatic arthritis	0.000501	0.000898	CcSEcCtD
Brimonidine—Insomnia—Dexamethasone—psoriatic arthritis	0.000501	0.000898	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000499	0.000895	CcSEcCtD
Brimonidine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000497	0.000891	CcSEcCtD
Brimonidine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000497	0.000891	CcSEcCtD
Brimonidine—Discomfort—Prednisone—psoriatic arthritis	0.000497	0.000891	CcSEcCtD
Brimonidine—Mental disorder—Methotrexate—psoriatic arthritis	0.000497	0.000891	CcSEcCtD
Brimonidine—Erythema—Methotrexate—psoriatic arthritis	0.000494	0.000885	CcSEcCtD
Brimonidine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000489	0.000876	CcSEcCtD
Brimonidine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000487	0.000874	CcSEcCtD
Brimonidine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000487	0.000874	CcSEcCtD
Brimonidine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000483	0.000867	CcSEcCtD
Brimonidine—Oedema—Prednisone—psoriatic arthritis	0.000482	0.000864	CcSEcCtD
Brimonidine—Infection—Prednisone—psoriatic arthritis	0.000479	0.000859	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000478	0.000857	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000478	0.000857	CcSEcCtD
Brimonidine—Fatigue—Betamethasone—psoriatic arthritis	0.000477	0.000856	CcSEcCtD
Brimonidine—Fatigue—Dexamethasone—psoriatic arthritis	0.000477	0.000856	CcSEcCtD
Brimonidine—Shock—Prednisone—psoriatic arthritis	0.000474	0.00085	CcSEcCtD
Brimonidine—Pain—Betamethasone—psoriatic arthritis	0.000473	0.000849	CcSEcCtD
Brimonidine—Pain—Dexamethasone—psoriatic arthritis	0.000473	0.000849	CcSEcCtD
Brimonidine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000473	0.000848	CcSEcCtD
Brimonidine—Tachycardia—Prednisone—psoriatic arthritis	0.000471	0.000844	CcSEcCtD
Brimonidine—Skin disorder—Prednisone—psoriatic arthritis	0.000468	0.00084	CcSEcCtD
Brimonidine—Vision blurred—Methotrexate—psoriatic arthritis	0.000465	0.000834	CcSEcCtD
Brimonidine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00045	0.000806	CcSEcCtD
Brimonidine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000449	0.000804	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000439	0.000788	CcSEcCtD
Brimonidine—Dizziness—Prednisolone—psoriatic arthritis	0.000439	0.000787	CcSEcCtD
Brimonidine—Asthenia—Triamcinolone—psoriatic arthritis	0.000438	0.000785	CcSEcCtD
Brimonidine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000437	0.000783	CcSEcCtD
Brimonidine—Insomnia—Prednisone—psoriatic arthritis	0.000436	0.000782	CcSEcCtD
Brimonidine—Paraesthesia—Prednisone—psoriatic arthritis	0.000433	0.000776	CcSEcCtD
Brimonidine—Pruritus—Triamcinolone—psoriatic arthritis	0.000432	0.000774	CcSEcCtD
Brimonidine—Cough—Methotrexate—psoriatic arthritis	0.000431	0.000772	CcSEcCtD
Brimonidine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000431	0.000772	CcSEcCtD
Brimonidine—Dyspepsia—Prednisone—psoriatic arthritis	0.000424	0.000761	CcSEcCtD
Brimonidine—Chest pain—Methotrexate—psoriatic arthritis	0.00042	0.000754	CcSEcCtD
Brimonidine—Myalgia—Methotrexate—psoriatic arthritis	0.00042	0.000754	CcSEcCtD
Brimonidine—Arthralgia—Methotrexate—psoriatic arthritis	0.00042	0.000754	CcSEcCtD
Brimonidine—Rash—Prednisolone—psoriatic arthritis	0.000418	0.00075	CcSEcCtD
Brimonidine—Dermatitis—Prednisolone—psoriatic arthritis	0.000418	0.000749	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000417	0.000748	CcSEcCtD
Brimonidine—Fatigue—Prednisone—psoriatic arthritis	0.000416	0.000745	CcSEcCtD
Brimonidine—Headache—Prednisolone—psoriatic arthritis	0.000416	0.000745	CcSEcCtD
Brimonidine—Discomfort—Methotrexate—psoriatic arthritis	0.000415	0.000745	CcSEcCtD
Brimonidine—Dizziness—Triamcinolone—psoriatic arthritis	0.000403	0.000723	CcSEcCtD
Brimonidine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000403	0.000722	CcSEcCtD
Brimonidine—Infection—Methotrexate—psoriatic arthritis	0.0004	0.000718	CcSEcCtD
Brimonidine—Asthenia—Betamethasone—psoriatic arthritis	0.000397	0.000712	CcSEcCtD
Brimonidine—Asthenia—Dexamethasone—psoriatic arthritis	0.000397	0.000712	CcSEcCtD
Brimonidine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000395	0.000708	CcSEcCtD
Brimonidine—Nausea—Prednisolone—psoriatic arthritis	0.000394	0.000707	CcSEcCtD
Brimonidine—Pruritus—Betamethasone—psoriatic arthritis	0.000392	0.000702	CcSEcCtD
Brimonidine—Pruritus—Dexamethasone—psoriatic arthritis	0.000392	0.000702	CcSEcCtD
Brimonidine—Skin disorder—Methotrexate—psoriatic arthritis	0.000391	0.000702	CcSEcCtD
Brimonidine—Rash—Triamcinolone—psoriatic arthritis	0.000385	0.00069	CcSEcCtD
Brimonidine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000384	0.000689	CcSEcCtD
Brimonidine—Rash—Methylprednisolone—psoriatic arthritis	0.000384	0.000688	CcSEcCtD
Brimonidine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000383	0.000688	CcSEcCtD
Brimonidine—Headache—Triamcinolone—psoriatic arthritis	0.000382	0.000685	CcSEcCtD
Brimonidine—Headache—Methylprednisolone—psoriatic arthritis	0.000381	0.000684	CcSEcCtD
Brimonidine—Hypotension—Methotrexate—psoriatic arthritis	0.000376	0.000675	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000367	0.000658	CcSEcCtD
Brimonidine—Dizziness—Betamethasone—psoriatic arthritis	0.000366	0.000656	CcSEcCtD
Brimonidine—Dizziness—Dexamethasone—psoriatic arthritis	0.000366	0.000656	CcSEcCtD
Brimonidine—Insomnia—Methotrexate—psoriatic arthritis	0.000364	0.000653	CcSEcCtD
Brimonidine—Nausea—Triamcinolone—psoriatic arthritis	0.000362	0.00065	CcSEcCtD
Brimonidine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000362	0.000649	CcSEcCtD
Brimonidine—Nausea—Methylprednisolone—psoriatic arthritis	0.000362	0.000648	CcSEcCtD
Brimonidine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000359	0.000644	CcSEcCtD
Brimonidine—Somnolence—Methotrexate—psoriatic arthritis	0.000358	0.000642	CcSEcCtD
Brimonidine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000355	0.000637	CcSEcCtD
Brimonidine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000355	0.000636	CcSEcCtD
Brimonidine—Rash—Betamethasone—psoriatic arthritis	0.000349	0.000626	CcSEcCtD
Brimonidine—Rash—Dexamethasone—psoriatic arthritis	0.000349	0.000626	CcSEcCtD
Brimonidine—Dermatitis—Betamethasone—psoriatic arthritis	0.000349	0.000625	CcSEcCtD
Brimonidine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000349	0.000625	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000348	0.000624	CcSEcCtD
Brimonidine—Fatigue—Methotrexate—psoriatic arthritis	0.000347	0.000623	CcSEcCtD
Brimonidine—Headache—Betamethasone—psoriatic arthritis	0.000347	0.000622	CcSEcCtD
Brimonidine—Headache—Dexamethasone—psoriatic arthritis	0.000347	0.000622	CcSEcCtD
Brimonidine—Asthenia—Prednisone—psoriatic arthritis	0.000346	0.00062	CcSEcCtD
Brimonidine—Pain—Methotrexate—psoriatic arthritis	0.000345	0.000618	CcSEcCtD
Brimonidine—Pruritus—Prednisone—psoriatic arthritis	0.000341	0.000612	CcSEcCtD
Brimonidine—Nausea—Betamethasone—psoriatic arthritis	0.000329	0.00059	CcSEcCtD
Brimonidine—Nausea—Dexamethasone—psoriatic arthritis	0.000329	0.00059	CcSEcCtD
Brimonidine—Dizziness—Prednisone—psoriatic arthritis	0.000319	0.000572	CcSEcCtD
Brimonidine—Rash—Prednisone—psoriatic arthritis	0.000304	0.000545	CcSEcCtD
Brimonidine—Dermatitis—Prednisone—psoriatic arthritis	0.000304	0.000545	CcSEcCtD
Brimonidine—Headache—Prednisone—psoriatic arthritis	0.000302	0.000542	CcSEcCtD
Brimonidine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000297	0.000532	CcSEcCtD
Brimonidine—Asthenia—Methotrexate—psoriatic arthritis	0.000289	0.000518	CcSEcCtD
Brimonidine—Nausea—Prednisone—psoriatic arthritis	0.000286	0.000513	CcSEcCtD
Brimonidine—Pruritus—Methotrexate—psoriatic arthritis	0.000285	0.000511	CcSEcCtD
Brimonidine—Dizziness—Methotrexate—psoriatic arthritis	0.000266	0.000478	CcSEcCtD
Brimonidine—Rash—Methotrexate—psoriatic arthritis	0.000254	0.000455	CcSEcCtD
Brimonidine—Dermatitis—Methotrexate—psoriatic arthritis	0.000254	0.000455	CcSEcCtD
Brimonidine—Headache—Methotrexate—psoriatic arthritis	0.000252	0.000453	CcSEcCtD
Brimonidine—Nausea—Methotrexate—psoriatic arthritis	0.000239	0.000429	CcSEcCtD
